Dark Light
Editor’s pick: Indapta Therapeutics

Editor’s pick: Indapta Therapeutics

Technology tamfitronics Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. Indapta Therapeutics is using a subset of natural killer cells found in healthy donors to supercharge monoclonal antibodies to fight cancer and autoimmune disease. Natural killer (NK) cells, the cytotoxic effector cells of the innate immune system, […]

Read More